
The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.

Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …

Coronavirus immunity in the world’s population may be more widespread than initially thought, even in those who have tested negative …

The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gilead’s …

The FDA has launched the Coronavirus Treatment Acceleration Program (CTAP) to quickly bring therapies and treatments to people suffering from …